查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1654190

人類原代細胞培養市場規模、佔有率、趨勢分析報告：按產品、應用、最終用途、地區和細分市場預測，2025-2030 年

Human Primary Cell Culture Market Size, Share & Trends Analysis Report By Product (Primary Cells, Primary Cell Culture Media, Reagents & Supplements), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

人類原代細胞培養市場的成長與趨勢

根據Grand View Research, Inc.的最新報告，全球人類原代細胞培養市場預計到2030年將達到71.5億美元，2025年至2030年期間的複合年成長率為11.05%。

原代細胞培養市場的成長歸因於幾個關鍵因素，例如對單株抗體的需求增加、癌症研究舉措的增加、製藥和生物技術公司的擴張、人類原代細胞相對於已建立細胞株的優勢增加以及政府對基於細胞的研究的支持增加。

單株抗體因其針對特定抗原的高度特異性和有效性而成為各種治療應用的核心。原代細胞在這些抗體的開發和測試中發揮著至關重要的作用，推動了市場對其的需求。製藥和生物技術產業嚴重依賴原代細胞進行藥物研發、毒性測試、疾病建模和個人化醫療，這些產業也正在經歷顯著的成長。精準醫療和標靶治療的轉變擴大了研發活動中對原代細胞的需求，使其對於推進現代醫療解決方案至關重要。

推動市場發展的另一個關鍵因素是對研究感染疾病的更有效模型的需求不斷增加。 COVID-19 大流行提高了人們對精確​​模型來測試候選疫苗、抗病毒藥物和其他治療方法的必要性的認知。人類原代細胞培養特別適合研究病毒感染，因為它們忠實地模擬了人類組織反應，這對於開發愛滋病毒、肝炎和流感等疾病的新疫苗和治療方法至關重要。此外，它們重現免疫細胞行為的能力使它們對於理解免疫反應和宿主-病原體相互作用至關重要。

雖然原代細胞比細胞株提供了更多生物學相關的研究模型，但其高成本會限制其可用性。獲取原代人類細胞通常需要來自專門的生物庫或商業供應商的資訊，並且這些細胞比已建立的細胞株昂貴得多。

人類原代細胞培養市場報告重點

  • 按產品分類，原代細胞部分在 2024 年佔據最大的市場佔有率。個人化醫療需求的不斷成長、3D 培養、器官晶片平台和微流體系統等技術進步以及對藥物研發和毒性測試的日益關注，正在推動這一領域的成長。
  • 根據應用，治療開發領域在 2024 年佔據市場主導地位。原代細胞對於生技藥品、單株抗體和疫苗的生產至關重要。此外，這場疫情證明了細胞培養在病毒學中的關鍵作用，並鼓勵了持續的投資。
  • 根據最終用途，製藥和生物技術公司將在 2024 年佔據市場主導地位。由於擴大採用基於細胞的模型進行藥物發現、開發和製造，製藥和生物製藥行業正在經歷顯著的市場成長。
  • 2024 年北美地區佔 41.12% 的市場佔有率。由於幾個關鍵因素，北美人類原代細胞培養產業正在經歷顯著成長。一個主要促進因素是癌症、糖尿病和心血管疾病等慢性疾病的發生率不斷上升，這導致利用原代細胞培養進行藥物開發的研究活動激增。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/支持市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 產業分析工具
    • 波特五力分析
    • PESTEL 分析
    • COVID-19影響分析

第4章 人類原代細胞培養市場：產品業務分析

  • 產品細分儀表板
  • 全球人類原代細胞培養市場產品差異分析
  • 2018 年至 2030 年全球人類原代細胞培養市場規模及趨勢分析（依產品分類）
  • 原代細胞
  • 原代細胞培養基
  • 試劑和補充劑

第5章 原代細胞培養市場：應用業務分析

  • 應用程式細分儀表板
  • 全球人類原代細胞培養市場應用趨勢分析
  • 2018 年至 2030 年全球人類原代細胞培養市場規模及趨勢分析（依應用）
  • 藥物研發
  • 開發治療方法
  • 再生醫學
  • 其他

6. 原代細胞培養市場-最終用途業務分析

  • 最終用途細分儀表板
  • 全球人類原代細胞培養市場最終用途變化分析
  • 2018 年至 2030 年全球人類原代細胞培養市場規模及趨勢分析（依最終用途）
  • 製藥和生物技術公司
  • CMO 和 CRO
  • 學術研究所

第 7 章 原代細胞培養市場：按產品、應用、最終用途和地區進行的估計和趨勢分析

  • 區域控制面板
  • 2018-2030 年市場規模、預測及趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 參與企業
  • 戰略地圖
  • 2024 年企業市場分析
  • 參與企業概況
    • Thermo Fisher Scientific Inc.
    • STEMCELL Technologies
    • Merck KGaA
    • Lonza
    • Cell Biologics, Inc.
    • PromoCell GMBH
    • ZenBio
    • AllCells
    • American Type Culture Collection
    • Axol Biosciences Ltd.
Product Code: GVR-4-68040-499-1

Human Primary Cell Culture Market Growth & Trends:

The global human primary cell culture market is anticipated to reach USD 7.15 billion by 2030 and grow at a CAGR of 11.05% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the primary cell culture market can be attributed to several key factors including the increasing demand for monoclonal antibodies, a rise in cancer research initiatives, the expanding number of pharmaceutical and biotechnology companies, the growing advantages of primary human cells over established cell lines, and increased government support for cell-based research.

Monoclonal antibodies have become central to various therapeutic applications due to their high specificity and effectiveness in targeting specific antigens. Primary cells play a critical role in developing and testing these antibodies, driving their demand in the market. The pharmaceutical and biotechnology industries, which rely heavily on primary cells for drug discovery, toxicity testing, disease modeling, and personalized medicine, are also experiencing significant growth. The shift toward precision medicine and targeted therapies has amplified the demand for primary cells in research and development activities, making them indispensable in advancing modern healthcare solutions.

Another significant factor propelling the market is the increasing demand for more effective models to study infectious diseases. The COVID-19 pandemic has heightened awareness around the need for accurate models to test vaccine candidates, antiviral drugs, and other therapeutic solutions. Human primary cell cultures are particularly suited for studying viral infections, as they closely mimic human tissue responses, which is critical in developing new vaccines and treatments for diseases like HIV, hepatitis, and influenza. Additionally, their ability to replicate the behavior of immune cells makes them essential in understanding immune responses and host-pathogen interactions.

While primary cells offer a more biologically relevant model for research than cell lines, their high cost can limit their accessibility. Procuring human primary cells often involves sourcing from specialized biorepositories or commercial vendors, and these cells can be considerably more expensive than established cell lines.

Human Primary Cell Culture Market Report Highlights:

  • Based on product, the primary cells segment held the largest market share in 2024. The rising demand for personalized medicine, technological advancements in 3D culture, organ-on-chip platforms, and microfluidic systems, and the rising focus on drug discovery and toxicology testing drive the segment's growth.
  • Based on application, the therapy development segment dominated the market with a share in 2024. Primary cells are essential for producing biologics, monoclonal antibodies, and vaccines. Moreover, the pandemic demonstrated the critical role of cell culture in virology, driving sustained investment.
  • Based on end use, the pharmaceutical & biotechnology companies segment dominated the market in 2024. The pharmaceutical and biopharmaceutical industries are witnessing substantial growth in the market, driven by the growing adoption of cell-based models for drug discovery, development, and manufacturing.
  • The North American region dominated the market share of 41.12% in 2024. North America's human primary cell culture industry is experiencing significant growth, driven by several key factors. A major contributor is the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders, which has led to a surge in research activities utilizing primary cell cultures for drug discovery and development.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Type Segment
    • 1.2.3. End Use Segment
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of chronic and infectious diseases
      • 3.2.1.2. Growing focus on personalized medicine
      • 3.2.1.3. Technological innovations in 3D cell culture
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of primary cells
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Human Primary Cell Culture Market: Product Business Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Global Human Primary Cell Culture Market Product Movement Analysis
  • 4.3. Global Human primary cell culture market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Primary Cells
    • 4.4.1. Global Primary Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Hematopoietic Cells
      • 4.4.2.1. Hematopoietic cells market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Skin Cells
      • 4.4.3.1. Skin cells market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Hepatocytes
      • 4.4.4.1. Hepatocytes market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5. Gastrointestinal Cells
      • 4.4.5.1. Gastrointestinal cells market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.6. Lung Cells
      • 4.4.6.1. Lung cells market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.7. Renal Cells
      • 4.4.7.1. Renal cells market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.8. Heart Cells
      • 4.4.8.1. Heart cells market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.9. Skeletal and Muscle Cells
      • 4.4.9.1. Skeletal and muscle cells market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.10. Other Primary Cells
      • 4.4.10.1. Other primary cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Primary Cell Culture Media
    • 4.5.1. Global Primary Cell Culture Media Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Serum-free Media
      • 4.5.2.1. Global Serum-free Media Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Serum-containing Media
      • 4.5.3.1. Global Serum-contaning Media Market and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Other Media
      • 4.5.4.1. Global Other Media Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Reagents and Supplements
    • 4.6.1. Global Reagents and Supplements Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.2. Attachment Solutions
      • 4.6.2.1. Global Attachment Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.3. Buffers and Salts
      • 4.6.3.1. Global Buffers and Salts Market and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.4. Sera
      • 4.6.4.1. Global Sera Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.5. Growth Factors and Cytokines
      • 4.6.5.1. Global Growth Factors and Cytokines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.6. Others
      • 4.6.6.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Primary Cell Culture Market: Application Business Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Global Human Primary Cell Culture Market Application, Movement Analysis
  • 5.3. Global Human primary cell culture market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Drug Discovery
    • 5.4.1. Global Drug Discovery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Therapy Development
    • 5.5.1. Global Therapy Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Regenerative Medicine
    • 5.6.1. Global Regenerative Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Other Applications
    • 5.7.1. Global Other Applications Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Primary Cell Culture Market: End Use Business Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Global Human Primary Cell Culture Market End Use Movement Analysis
  • 6.3. Global Human primary cell culture market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Global Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. CMOs & CROs
    • 6.5.1. Global CMOs & CROs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Academic Research Institutes
    • 6.6.1. Global Academic Research Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Primary Cell Culture Market: Regional Estimates & Trend Analysis by Product, Application, and End Use

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. North America Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. U.S. Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Canada Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Mexico Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. UK Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Germany Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. France Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Italy Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Spain Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Denmark Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Framework
      • 7.4.8.4. Sweden Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Framework
      • 7.4.9.4. Norway Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Japan Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. China Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. India Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Australia Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Thailand Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. South Korea
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. South Korea Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Brazil Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Argentina Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. South Africa Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Saudi Arabia Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. UAE Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Kuwait Human Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2024
  • 8.4. Participant's Overview
    • 8.4.1. Thermo Fisher Scientific Inc.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. STEMCELL Technologies
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Merck KGaA
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Lonza
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Cell Biologics, Inc.
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. PromoCell GMBH
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. ZenBio
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. AllCells
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. American Type Culture Collection
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Axol Biosciences Ltd.
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global human primary cell culture market , by product, 2018 - 2030 (USD million)
  • Table 4 Global human primary cell culture market , by application , 2018 - 2030 (USD million)
  • Table 5 Global human primary cell culture market , by end use, 2018 - 2030 (USD million)
  • Table 6 Global human primary cell culture market , by region, 2018 - 2030 (USD million)
  • Table 7 North America human primary cell culture market , by country, 2018 - 2030 (USD million)
  • Table 8 North America human primary cell culture market , by product, 2018 - 2030 (USD million)
  • Table 9 North America human primary cell culture market , by application , 2018 - 2030 (USD million)
  • Table 10 North America human primary cell culture market , by end use, 2018 - 2030 (USD million)
  • Table 11 U.S. human primary cell culture market , by product, 2018 - 2030 (USD million)
  • Table 12 U.S. human primary cell culture market , by application , 2018 - 2030 (USD million)
  • Table 13 U.S. human primary cell culture market , by end use, 2018 - 2030 (USD million)
  • Table 14 Canada human primary cell culture market , by product, 2018 - 2030 (USD million)
  • Table 15 Canada human primary cell culture market , by application , 2018 - 2030 (USD million)
  • Table 16 Canada human primary cell culture market , by end use, 2018 - 2030 (USD million)
  • Table 17 Mexico human primary cell culture market , by product, 2018 - 2030 (USD million)
  • Table 18 Mexico human primary cell culture market , by application , 2018 - 2030 (USD million)
  • Table 19 Mexico human primary cell culture market , by end use, 2018 - 2030 (USD million)
  • Table 20 Europe human primary cell culture market , by country, 2018 - 2030 (USD million)
  • Table 21 Europe human primary cell culture market , by product, 2018 - 2030 (USD million)
  • Table 22 Europe human primary cell culture market , by application , 2018 - 2030 (USD million)
  • Table 23 Europe human primary cell culture market , by end use, 2018 - 2030 (USD million)
  • Table 24 UK human primary cell culture market , by product, 2018 - 2030 (USD million)
  • Table 25 UK human primary cell culture market , by application , 2018 - 2030 (USD million)
  • Table 26 UK human primary cell culture market , by end use, 2018 - 2030 (USD million)
  • Table 27 Germany human primary cell culture market , by product, 2018 - 2030 (USD million)
  • Table 28 Germany human primary cell culture market , by application , 2018 - 2030 (USD million)
  • Table 29 Germany human primary cell culture market , by end use, 2018 - 2030 (USD million)
  • Table 30 France human primary cell culture market , by product, 2018 - 2030 (USD million)
  • Table 31 France human primary cell culture market , by application , 2018 - 2030 (USD million)
  • Table 32 France human primary cell culture market , by end use, 2018 - 2030 (USD million)
  • Table 33 Italy human primary cell culture market , by product, 2018 - 2030 (USD million)
  • Table 34 Italy human primary cell culture market , by application , 2018 - 2030 (USD million)
  • Table 35 Italy human primary cell culture market , by end use, 2018 - 2030 (USD million)
  • Table 36 Spain human primary cell culture market , by product, 2018 - 2030 (USD million)
  • Table 37 Spain human primary cell culture market , by application , 2018 - 2030 (USD million)
  • Table 38 Spain human primary cell culture market , by end use, 2018 - 2030 (USD million)
  • Table 39 Denmark human primary cell culture market , by product, 2018 - 2030 (USD million)
  • Table 40 Denmark human primary cell culture market , by application , 2018 - 2030 (USD million)
  • Table 41 Denmark human primary cell culture market , by end use, 2018 - 2030 (USD million)
  • Table 42 Sweden human primary cell culture market , by product, 2018 - 2030 (USD million)
  • Table 43 Sweden human primary cell culture market , by application , 2018 - 2030 (USD million)
  • Table 44 Sweden human primary cell culture market , by end use, 2018 - 2030 (USD million)
  • Table 45 Norway human primary cell culture market , by product, 2018 - 2030 (USD million)
  • Table 46 Norway human primary cell culture market , by application , 2018 - 2030 (USD million)
  • Table 47 Norway human primary cell culture market , by end use, 2018 - 2030 (USD million)
  • Table 48 Asia Pacific human primary cell culture market , by country, 2018 - 2030 (USD million)
  • Table 49 Asia Pacific human primary cell culture market , by product, 2018 - 2030 (USD million)
  • Table 50 Asia Pacific human primary cell culture market , by application , 2018 - 2030 (USD million)
  • Table 51 Asia Pacific human primary cell culture market , by end use, 2018 - 2030 (USD million)
  • Table 52 Japan human primary cell culture market , by product, 2018 - 2030 (USD million)
  • Table 53 Japan human primary cell culture market , by application , 2018 - 2030 (USD million)
  • Table 54 Japan human primary cell culture market , by end use, 2018 - 2030 (USD million)
  • Table 55 China human primary cell culture market , by product, 2018 - 2030 (USD million)
  • Table 56 China human primary cell culture market , by application , 2018 - 2030 (USD million)
  • Table 57 China human primary cell culture market , by end use, 2018 - 2030 (USD million)
  • Table 58 India human primary cell culture market , by product, 2018 - 2030 (USD million)
  • Table 59 India human primary cell culture market , by application , 2018 - 2030 (USD million)
  • Table 60 India human primary cell culture market , by end use, 2018 - 2030 (USD million)
  • Table 61 Australia human primary cell culture market , by product, 2018 - 2030 (USD million)
  • Table 62 Australia human primary cell culture market , by application , 2018 - 2030 (USD million)
  • Table 63 Australia human primary cell culture market , by end use, 2018 - 2030 (USD million)
  • Table 64 Thailand human primary cell culture market , by product, 2018 - 2030 (USD million)
  • Table 65 Thailand human primary cell culture market , by application , 2018 - 2030 (USD million)
  • Table 66 Thailand human primary cell culture market , by end use, 2018 - 2030 (USD million)
  • Table 67 South Korea human primary cell culture market , by product, 2018 - 2030 (USD million)
  • Table 68 South Korea human primary cell culture market , by application , 2018 - 2030 (USD million)
  • Table 69 South Korea human primary cell culture market , by end use, 2018 - 2030 (USD million)
  • Table 70 Latin America human primary cell culture market , by country, 2018 - 2030 (USD million)
  • Table 71 Latin America human primary cell culture market , by product, 2018 - 2030 (USD million)
  • Table 72 Latin America human primary cell culture market , by application , 2018 - 2030 (USD million)
  • Table 73 Latin America human primary cell culture market , by end use, 2018 - 2030 (USD million)
  • Table 74 Brazil human primary cell culture market , by product, 2018 - 2030 (USD million)
  • Table 75 Brazil human primary cell culture market , by application , 2018 - 2030 (USD million)
  • Table 76 Brazil human primary cell culture market , by end use, 2018 - 2030 (USD million)
  • Table 77 Argentina human primary cell culture market , by product, 2018 - 2030 (USD million)
  • Table 78 Argentina human primary cell culture market , by application , 2018 - 2030 (USD million)
  • Table 79 Argentina human primary cell culture market , by end use, 2018 - 2030 (USD million)
  • Table 80 Middle East & Africa human primary cell culture market , by country, 2018 - 2030 (USD million)
  • Table 81 Middle East & Africa human primary cell culture market , by product, 2018 - 2030 (USD million)
  • Table 82 Middle East & Africa human primary cell culture market , by application , 2018 - 2030 (USD million)
  • Table 83 Middle East & Africa human primary cell culture market , by end use, 2018 - 2030 (USD million)
  • Table 84 South Africa human primary cell culture market , by product, 2018 - 2030 (USD million)
  • Table 85 South Africa human primary cell culture market , by application , 2018 - 2030 (USD million)
  • Table 86 South Africa human primary cell culture market , by end use, 2018 - 2030 (USD million)
  • Table 87 Saudi Arabia human primary cell culture market , by product, 2018 - 2030 (USD million)
  • Table 88 Saudi Arabia human primary cell culture market , by application , 2018 - 2030 (USD million)
  • Table 89 Saudi Arabia human primary cell culture market , by end use, 2018 - 2030 (USD million)
  • Table 90 UAE human primary cell culture market , by product, 2018 - 2030 (USD million)
  • Table 91 UAE human primary cell culture market , by application , 2018 - 2030 (USD million)
  • Table 92 UAE human primary cell culture market , by end use, 2018 - 2030 (USD million)
  • Table 93 Kuwait human primary cell culture market , by product, 2018 - 2030 (USD million)
  • Table 94 Kuwait human primary cell culture market , by application , 2018 - 2030 (USD million)
  • Table 95 Kuwait human primary cell culture market , by end use, 2018 - 2030 (USD million)
  • Table 96 Participant's overview
  • Table 97 Financial performance

List of Figures

  • Fig. 1 Human primary cell culture market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot - 1
  • Fig. 14 Segment snapshot - 2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Cell culture market value, 2023 (USD billion)
  • Fig. 17 Market trends & outlook
  • Fig. 18 PESTEL analysis
  • Fig. 19 Porter's five forces analysis
  • Fig. 20 Human primary cell culture market: Product outlook and key takeaways
  • Fig. 21 Human primary cell culture market: Product movement analysis
  • Fig. 22 Primary cells market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 23 Hematopoietic cells market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 24 Skin cells market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 25 Hepatocytes market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 26 Gastrointestinal cells market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 27 Lung cells market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 28 Renal cells market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 29 Heart cells market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 30 Skeletal & muscle cells market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 31 Other primary cells market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 32 Primary cell culture media market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 33 Serum-free media market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 34 Serum-containing media market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 35 Other market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 36 Reagents & supplements market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 37 Attachment solutions market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 38 Buffers & salts market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 39 Sera market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 40 Growth factors & cytokines market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 41 Others market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 42 Human primary cell culture market: Application outlook and key takeaways
  • Fig. 43 Human primary cell culture market: Application movement analysis
  • Fig. 44 Drug discovery market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 45 Therapy development market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 46 Regenerative medicine market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 47 Others market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 48 Human primary cell culture market: End use outlook & key takeaways
  • Fig. 49 Human primary cell culture market: End use, movement analysis
  • Fig. 50 Pharmaceutical & biopharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 51 CMOs & CROs market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 52 Academic research institutes market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 53 Regional marketplace outlook, 2024 & 2030 (USD Million)
  • Fig. 54 Regional marketplace: Key takeaways
  • Fig. 55 North America human primary cell culture market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 56 Key country dynamics
  • Fig. 57 U.S. human primary cell culture market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Canada human primary cell culture market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Mexico human primary cell culture market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Europe human primary cell culture market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Germany human primary cell culture market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 65 Key country dynamics
  • Fig. 66 UK human primary cell culture market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 67 Key country dynamics
  • Fig. 68 France human primary cell culture market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Italy human primary cell culture market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Spain human primary cell culture market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Denmark human primary cell culture market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Sweden human primary cell culture market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Norway human primary cell culture market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 79 Asia Pacific human primary cell culture market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Japan human primary cell culture market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 China human primary cell culture market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 India human primary cell culture market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Australia Human primary cell culture market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Thailand human primary cell culture market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 South Korea human primary cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Latin America human primary cell culture market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 Brazil human primary cell culture market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 Argentina human primary cell culture market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 97 MEA human primary cell culture market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 98 Key country dynamics
  • Fig. 99 South Africa human primary cell culture market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 100 Key country dynamics
  • Fig. 101 Saudi Arabia human primary cell culture market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 102 Key country dynamics
  • Fig. 103 UAE human primary cell culture market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 104 Key country dynamics
  • Fig. 105 Kuwait human primary cell culture market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 106 Market participant categorization
  • Fig. 107 Global human primary cell culture company position analysis, 2024
  • Fig. 108 Strategic framework